EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration

László Juhász iD, Krisztina Spisák, Boglárka Zsuzsa Szolnoki, Anna Nászai, Ágnes Szabó, Attila Rutai, Szabolcs Péter Tallósy, Andrea Szabó, József Toldi, Masaru Tanaka, Keiko Takeda, Kinuyo Ozaki und 6 weitere

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von László Juhász und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Surgical Research, University of Szeged, Albert Szent-Györgyi Medical School, Szeged, Hungary. Hauptthemen laut MEDLINE: Kynurenine, Mitochondria, Transaminases, Brain. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem, National Research, Development and Innovation Office, Magyarország Kormánya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous illnesses, including neurological and mental disorders, have been associated with mitochondrial dysfunction. Disruptions in mitochondrial respiration and energy production have been linked to dysmetabolism of the tryptophan (Trp)‐kynurenine (KYN) pathway, which produces a diverse array of bioactive metabolites. Kynurenic acid (KYNA) is a putative neuroprotectant. The exact mechanisms through which Trp‐KYN metabolic dysregulation affects mitochondrial function remain largely unclear. This study investigates the impact of the genetic deletion of kynurenine aminotransferase (KAT) enzymes, which are responsible for KYNA synthesis, on mitochondrial function, specifically mitochondrial respiration and ATP synthesis, and its potential role in neuropsychiatric pathology. CRISPR/Cas9‐induced knockout mouse strains kat1 −/− , kat2 −/− , and kat3 −/− were generated. Eight‐to‐ten‐week‐old male mice were used, and cerebral and hepatic respiration, complex I‐ and II‐linked oxidative phosphorylation (CI and CII OXPHOS), and complex IV (CIV) activity were measured using high‐resolution respirometry. Mitochondrial membrane potential changes were measured with Fluorescence‐Sensor Blue and safranin dye. KAT knockout mice exhibited significantly lower cerebellar respiration (CI OXPHOS, CII OXPHOS, and CIV activity) compared to wild‐type mice. Lower baseline respiration and attenuated OXPHOS activities were observed in the hippocampus and striatum, particularly in kat2 −/− and kat3 −/− mice. Non‐neuronal tissues showed reduced CIV activity, while ADP‐stimulated CI and CII OXPHOS remained unchanged. The deletion of the KAT genes significantly impairs mitochondrial respiration and ATP synthesis, potentially contributing to pathogenesis. This study highlights the importance of KYNA in mitochondrial function, offering new insights into potential therapeutic targets for various disorders. Targeting the KYN pathway could mitigate mitochondrial dysfunction in a variety of diseased conditions. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineMitochondriaTransaminasesBrainAnimalsMice, KnockoutMiceMaleCell RespirationMice, Inbred C57BLMembrane Potential, MitochondrialOxidative Phosphorylation

Stichwörter der Autor:innen

kynurenic acidkynurenine aminotransferasemitochondrial dysfunctionneurodegenerative diseasespsychiatric diseasestransgenic micetryptophan

Substanzen

KynurenineTransaminaseskynurenine-oxoglutarate transaminase

Autor:innen und Institutionen

  • Institute of Surgical Research, University of Szeged, Albert Szent-Györgyi Medical School, Szeged, Hungary.
  • Department of Neurology, University of Szeged, Albert Szent-Györgyi Medical School, Szeged, Hungary.
  • HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Danube Neuroscience Research Laboratory, Szeged, Hungary.
  • Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.
  • Department of Biomedicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Center of Biomedical Research, Research Center for Human Disease Modeling, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

ORCID-Profile: László Juhász

Förderung

  • Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem
  • National Research, Development and Innovation Office
  • Magyarország Kormánya
  • Japan Society for the Promotion of Science
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Zitieren

APA

Juhász, L., Spisák, K., Szolnoki, B. Z., Nászai, A., Szabó, Á., Rutai, A., Tallósy, S. P., Szabó, A., Toldi, J., Tanaka, M., Takeda, K., Ozaki, K., Inoue, H., Yamamoto, S., Ono, E., Boros, M., Kaszaki, J., & Vécsei, L. (2025). The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70075

Vancouver

Juhász L, Spisák K, Szolnoki BZ, Nászai A, Szabó Á, Rutai A, et al. The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70075

BibTeX
@article{Juhsz2025,
  author = {Juhász, László and Spisák, Krisztina and Szolnoki, Boglárka Zsuzsa and Nászai, Anna and Szabó, Ágnes and Rutai, Attila and Tallósy, Szabolcs Péter and Szabó, Andrea and Toldi, József and Tanaka, Masaru and Takeda, Keiko and Ozaki, Kinuyo and Inoue, Hiromi and Yamamoto, Sayo and Ono, Etsuro and Boros, Mihály and Kaszaki, József and Vécsei, László},
  title = {The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70075}
}
Kostenlos starten →